Moreover, we demonstrated that HCC-SR cells can be sensitized to sorafenib-induced ferroptosis both in vivo and in vitro via the FASN/HIF1α/SLC7A11 pathway. This evidence concerns the gene SLC7A11 and hepatocellular carcinoma.